Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Castello De La Plana – page 9

102 clinical trials in Castello De La Plana, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Castello De La Plana at a glance
102
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

102 trials in Castello De La Plana

Open in trial search

Study on the Effect of Tamoxifen and Chemotherapy in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer with Low Recurrence Scores

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama

Study Comparing Standard Chemotherapy with Letrozole and Abemaciclib for High/Intermediate Risk HR-Positive, HER2-Negative Breast Cancer Patients

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama

Breast cancer+2

Not recruiting

Study of Durvalumab, Olaparib, and Fulvestrant for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer with Specific Genetic Alterations

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Unicancer

Study Comparing Docetaxel Alone and Docetaxel with Radium-223 for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Radium RA 223 dichloride
  • Sponsor:Memorial Sloan Kettering Cancer Center

Narcolepsy

Not recruiting

Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 1

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:ALKS 2680
  • Sponsor:Alkermes Inc.

Study on the Effectiveness and Safety of Remibrutinib for Teens with Chronic Spontaneous Urticaria Not Controlled by H1-Antihistamines

Registered drug
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Castello De La Plana

What the registry says about research in the country

01 Autoimmune Conditions

Multiple trials exploring treatments for Sjögren's Syndrome and systemic lupus erythematosus, evaluating novel therapies like sibeprenlimab and dapirolizumab pegol for improving disease management and patient outcomes.

  • Sjögren's Disease Management
  • Lupus Treatment Studies
  • Psoriatic Arthritis Research

Focus on long-term safety and effectiveness of new therapeutic approaches for chronic autoimmune conditions.

02 Oncology Research

Comprehensive studies on various cancer types, including lung cancer, breast cancer, and prostate cancer, investigating innovative treatment combinations and targeted therapies.

  • Advanced Melanoma Treatment
  • HER2-Positive Breast Cancer Therapy
  • Localized Colon Cancer Management

Emphasis on personalized treatment approaches and combination therapies to improve patient outcomes.

03 Respiratory and Allergic Conditions

Research focusing on allergic rhinitis, asthma management, and novel treatments for respiratory conditions, including standardization of allergen extracts and evaluation of new delivery systems.

  • Asthma Control Studies
  • Allergy Immunotherapy
  • Respiratory Treatment Innovation

Investigation of advanced therapeutic options for both acute and chronic respiratory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.